Carriers of pathogenic MLH1, MSH2, and MSH6 mutations can reduce their risk of developing LS-associated endometrial and ovarian cancers through preventive hysterectomy with salpingo-oophorectomy. The gene discussed is MLH1; the disease is ovarian cancer.